PCDH10 and cancer: This suggests that PCDH10 methylation can be used as a marker for early stage cancer diagnosis (Yu et al., 2010), and the counting of methylated CpG islands has clinical prognostic assessment applicability (Deng et al., 2014; Hou et al., 2015).